Concepedia

Author

Angélica Corral

Instituto de Salud Carlos IIIORCID

Also Known As

A. CORRAL, A. Corral, Angelica Corral, Angélica Corral, Angélica Corral

41

Publications

1.2K

Citations

22

H-Index

75

Concepts

All Affiliations

Instituto de Salud Carlos IIIHospital Clínico San CarlosUniversidad Carlos III de MadridMarqués de Valdecilla University HospitalCenters for Disease Control and Prevention
AC

About

Angélica Corral is an author at Instituto de Salud Carlos III specializing in medicine, hiv, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

529

2

Public Health

6

6

301

3

Engineering

3

3

56

4

Biomedical Engineering

2

2

41

5

Health Sciences

1

1

16

Angélica Corral

×

29

Publications

1.1K

Citations

21

H-Index

YearCitations

Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1

Sonia Rodríguez‐Nóvoa, Pablo Barreiro, A. Rendon,

Clinical Infectious Diseases

2005

117

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

Silvina Masciotra, Ae S. Youngpairoj, Amanda McNulty,

AIDS

2007

74

Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

Natalia Zahonero, Angélica Corral, Miguel Arredondo,

Journal of Clinical Microbiology

2009

71

Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

Carmen de Mendoza, Carly A. Rodriguez, Javier Colomina,

Clinical Infectious Diseases

2005

58

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

Eva Poveda, Carmen de Mendoza, Luz Martı́n-Carbonero,

Journal of Antimicrobial Chemotherapy

2007

57

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

Julie Sheldon, Angélica Corral, Berta Rodés,

AIDS

2005

53

Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

Eva Poveda, Verónica Briz, Carmen de Mendoza,

Journal of Medical Virology

2007

44

Preparation and Characterization of Antimicrobial Films Based on LDPE/Ag Nanoparticles with Potential Uses in Food and Health Industries

D. Olmos, Gloria María Pontes-Quero, Angélica Corral,

Nanomaterials

2018

44

Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients

Carmen de Mendoza, Angélica Corral, Germán Ramírez‐Olivencia,

AIDS Research and Human Retroviruses

2007

42

High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor

Eduardo Seclén, María del Mar González, Angélica Corral,

AIDS

2010

41

Page 1